| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 06/22/2005 | CN1207283C 4-aminopiperidine derivatives and their use as medicine |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/21/2005 | US6908942 Carbocyclic oxy amines such as 2,2-dimethyl-3-(4-fluorobenzyl) ether-4-methoxy-6-(4-methoxybenzyl)amino Benzopyran and libraries, used for prophylaxis of eating disorders induced by lipid peroxidation; antioxidants |
| 06/21/2005 | US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 06/21/2005 | US6908931 1-(2,2-diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline- 2-carbaldehyde; for treating sleep disorders |
| 06/21/2005 | US6908924 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections |
| 06/21/2005 | US6908923 Compositions and methods for treating heart failure |
| 06/21/2005 | US6908921 Quinoxalinone derivatives as bradykinin B1 antagonists |
| 06/21/2005 | US6908919 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 06/21/2005 | CA2250372C 6-phenylpyridyl-2-amine derivatives |
| 06/16/2005 | WO2005054430A2 Hepatitis c virus inhibitors |
| 06/16/2005 | WO2005054239A1 2-aminopyrimidine derivatives |
| 06/16/2005 | WO2005054229A1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics |
| 06/16/2005 | WO2005054227A1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
| 06/16/2005 | WO2005054210A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/16/2005 | WO2005054201A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/16/2005 | WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/16/2005 | WO2005053663A2 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure |
| 06/16/2005 | WO2005040116A3 Indolinone derivatives and their use in treating disease-states such as cancer |
| 06/16/2005 | WO2005025293A3 Fused ring heterocycles as potassium channel modulators |
| 06/16/2005 | WO2005002552A3 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/16/2005 | WO2004096286A3 Antiviral phosphonate analogs |
| 06/16/2005 | WO2004058753A8 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| 06/16/2005 | US20050131050 Reacting ethyl trifluoroacetate with 4'fluoroacetophenone and 4-sulphonamidophenyl hydrazine |
| 06/16/2005 | US20050131049 Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence |
| 06/16/2005 | US20050131042 HIV protease inhibiting compounds |
| 06/16/2005 | US20050131022 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer |
| 06/16/2005 | US20050131019 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
| 06/16/2005 | US20050131014 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents |
| 06/16/2005 | US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents |
| 06/16/2005 | US20050130997 Pyrimidinone viral polymerase inhibitors |
| 06/16/2005 | US20050130989 (3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)(4-phenylpiperazin-1-yl)methanone; inhibit tubulin polymerization; cancer |
| 06/16/2005 | US20050130977 Inhibitors of akt activity |
| 06/16/2005 | US20050130953 Pharmacological uses of azetidine derivatives |
| 06/16/2005 | US20050130843 Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(ethi)ones |
| 06/16/2005 | DE10353093A1 Unsymmetrische lineare organische Oligomere Asymmetrical linear organic oligomers |
| 06/16/2005 | CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/16/2005 | CA2547887A1 Protein modifier production inhibitor |
| 06/16/2005 | CA2546657A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/15/2005 | EP1541563A1 Ccr4 antagonist and medicinal use thereof |
| 06/15/2005 | EP1541559A1 5-substituted isoquinoline derivative |
| 06/15/2005 | EP1541551A1 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 06/15/2005 | EP1539766A1 Calcitonin gene related peptide receptor antagonists |
| 06/15/2005 | EP1539760A2 Azapurine derivatives |
| 06/15/2005 | EP1539754A2 Benzimidazole quinolinones and uses thereof |
| 06/15/2005 | EP1539742A1 Indole derivatives useful as histamine h3 antagonists |
| 06/15/2005 | EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/15/2005 | EP1539734A1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents |
| 06/15/2005 | EP1539733A2 Azabicyclic compounds are central nervous system active agents |
| 06/15/2005 | EP1539730A1 Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 06/15/2005 | EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives |
| 06/15/2005 | EP1539716A1 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 06/15/2005 | EP1539712A1 Pyrimidine derivatives and their use as cb2 modulators |
| 06/15/2005 | EP1539708A1 Benzimidazolones and their use as cytokine inhibitors |
| 06/15/2005 | EP1539700A1 8-hydroxy quinoline derivatives |
| 06/15/2005 | EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | EP1539178A2 Protease inhibitors |
| 06/15/2005 | EP1539163A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 06/15/2005 | EP1539159A1 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 06/15/2005 | EP1539158A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 06/15/2005 | EP1539151A1 Biaryl compounds having anti-infective activity |
| 06/15/2005 | EP1539147A1 Methods of treating microbial infections in humans and animals |
| 06/15/2005 | EP1539141A1 -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| 06/15/2005 | EP1278740B1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 06/15/2005 | EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 06/15/2005 | EP1206468B1 Substituted thienyl(amino)sulfonylureas |
| 06/15/2005 | EP1150973B1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 06/15/2005 | EP1114031B1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 06/15/2005 | EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 06/15/2005 | CN1628100A Gamma secretase inhibitors |
| 06/15/2005 | CN1628095A Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient |
| 06/15/2005 | CN1627945A Quinoline derivatives as NPY antagonists |
| 06/15/2005 | CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 06/15/2005 | CN1626534A Steroid receptor modulator compounds and methods |
| 06/15/2005 | CN1626533A Process for preparation of sulfonamide derivs. and crystals thereof |
| 06/15/2005 | CN1626532A Amide compounds |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/14/2005 | US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran |
| 06/14/2005 | US6906193 N-type calcium channel antagonists for the treatment of pain |
| 06/14/2005 | US6906103 Compounds possessing antibacterial, antifungal or antitumor activity |
| 06/14/2005 | US6906095 Central nervous system disorders; anxiolytic agents; antidepressants; muscular disorders |
| 06/14/2005 | US6906093 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 06/14/2005 | US6906088 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent |
| 06/14/2005 | US6906084 Indole derivatives as factor Xa inhibitors |
| 06/14/2005 | US6906082 Cholesteryl ester transfer protein inhibitor; anticholesterol agents, cardiovascular disorders; synergistic mixture |
| 06/14/2005 | US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/14/2005 | US6906063 For therapy and prophylaxis of thrombosis in a mammal |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6905786 A thin layer contains aromatic tert-amine compound, sandwiched between a pair of electrodes; brightness |
| 06/14/2005 | CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/14/2005 | CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 06/09/2005 | WO2005051974A2 Novel molecules for regulating cell death |
| 06/09/2005 | WO2005051941A1 Thione derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same |
| 06/09/2005 | WO2005051937A2 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof |
| 06/09/2005 | WO2005051923A1 Quinazoline derivatives |
| 06/09/2005 | WO2005051917A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 06/09/2005 | WO2005051913A1 Cyclic amine derivative having heteroaryl ring |